Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
357 trials across Europe, recruiting first
Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors
NorwayStudy on Atezolizumab for Patients with Lung and Liver Cancer Using Digital Health Solutions
AustriaStudy of Afamelanotide for Patients with Erythropoietic Protoporphyria (EPP)
BelgiumStudy on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
AustriaStudy of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation
AustriaStudy on Simvastatin for Treating Primary Sclerosing Cholangitis in Patients
SwedenStudy on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure
AustriaStudy of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment
AustriaLong-term Study on Treatment Response in Chronic Hepatitis B Patients Using Bepirovirsen
BulgariaStudy on GSK4532990 for Adults with Nonalcoholic Steatohepatitis (NASH)
BelgiumStudy on the Effects of Dersimelagon Phosphate for Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria
BulgariaStudy on the Effects of RBD1016 and Tenofovir Alafenamide for Patients with Chronic Hepatitis D Infection
SwedenThe therapies tested most often in Hepatobiliary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
